Who
Chris Francis
Officer
Company insider
Files Form 4 as: Officer, Wave Life Sciences.
In numbers
- Trades disclosed
- 109
- Buys
- 0
- Sells
- 19
- Bought
- $0
- Sold
- $16.5M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 16 Jun 2016
- Last trade
- 26 Feb 2026
- Last filed
- 27 Feb 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 26 Feb 2026filed 27 Feb 2026 | WVE Wave Life SciencesBiotechnology | SEC FORM 4 Code M | $69K17,900 at $3.87 | filing |
| 26 Feb 2026filed 27 Feb 2026 | WVE Wave Life SciencesBiotechnology | SEC FORM 4 Sold | $270K17,900 at $15.09 | filing |
| 26 Feb 2026filed 27 Feb 2026 | WVE Wave Life SciencesBiotechnology | SEC FORM 4 Code M | $73K15,294 at $4.75 | filing |
| 26 Feb 2026filed 27 Feb 2026 | WVE Wave Life Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —17,900 at $0.00 | filing |
| 26 Feb 2026filed 27 Feb 2026 | WVE Wave Life Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —15,294 at $0.00 | filing |
| 26 Feb 2026filed 27 Feb 2026 | WVE Wave Life SciencesBiotechnology | SEC FORM 4 Sold | $229K15,294 at $15.00 | filing |
| 26 Feb 2026filed 27 Feb 2026 | WVE Wave Life Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —17,900 at $0.00 | filing |
| 26 Feb 2026filed 27 Feb 2026 | WVE Wave Life Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —15,294 at $0.00 | filing |
| 26 Feb 2026filed 27 Feb 2026 | WVE Wave Life SciencesBiotechnology | SEC FORM 4 Code M | $69K17,900 at $3.87 | filing |
| 26 Feb 2026filed 27 Feb 2026 | WVE Wave Life SciencesBiotechnology | SEC FORM 4 Sold | $270K17,900 at $15.09 | filing |
| 26 Feb 2026filed 27 Feb 2026 | WVE Wave Life SciencesBiotechnology | SEC FORM 4 Code M | $73K15,294 at $4.75 | filing |
| 26 Feb 2026filed 27 Feb 2026 | WVE Wave Life SciencesBiotechnology | SEC FORM 4 Sold | $229K15,294 at $15.00 | filing |
| 9 Feb 2026filed 11 Feb 2026 | WVE Wave Life SciencesBiotechnology | SEC FORM 4 Sold | $25K1,883 at $13.45 | filing |
| 9 Feb 2026filed 11 Feb 2026 | WVE Wave Life SciencesBiotechnology | SEC FORM 4 Sold | $25K1,883 at $13.45 | filing |
| 5 Feb 2026filed 11 Feb 2026 | WVE Wave Life SciencesBiotechnology | SEC FORM 4 Code A | —38,750 at $0.00 | filing |
| 5 Feb 2026filed 11 Feb 2026 | WVE Wave Life Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —232,500 at $0.00 | filing |
| 5 Feb 2026filed 11 Feb 2026 | WVE Wave Life Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —232,500 at $0.00 | filing |
| 5 Feb 2026filed 11 Feb 2026 | WVE Wave Life SciencesBiotechnology | SEC FORM 4 Code A | —38,750 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | WVE Wave Life SciencesBiotechnology | SEC FORM 4 Code M | $29K9,375 at $3.14 | filing |
| 2 Jan 2026filed 6 Jan 2026 | WVE Wave Life SciencesBiotechnology | SEC FORM 4 Sold | $129K8,080 at $15.92 | filing |
News
Wave Life Sciences Third Quarter 2026 Financial Results Scheduled for October 27, 2026WVE · manilatimes.net · 20 Oct 2026Wave Life Sciences to Host Virtual Research Day on Wednesday, November 4, 2026WVE · manilatimes.net · 19 Oct 2026WAVE Life Sciences (NASDAQ:WVE) and Alumis (NASDAQ:ALMS) Head to Head ComparisonWVE · dailypolitical.com · 18 Oct 2026
0 headlines in the last 90 days name Chris Francis; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.